Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.
Title | Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Vareta, G., Georgianos P. I., Vaios V., Sgouropoulou V., Georgianou E. I., Leivaditis K., Mavromatidis K., Dounousi E., Papagianni A., Balaskas E. V., Zebekakis P. E., & Liakopoulos V. |
Journal | Am J Hypertens |
Volume | 35 |
Issue | 11 |
Pagination | 918-922 |
Date Published | 2022 Nov 02 |
ISSN | 1941-7225 |
Keywords | Antihypertensive Agents, Blood Pressure, Cross-Sectional Studies, Humans, Hypertension, Peritoneal Dialysis, Prevalence |
Abstract | BACKGROUND: Apparent treatment-resistant hypertension (aTRH) is defined as failure to achieve adequate blood pressure (BP) control despite taking ≥3 antihypertensive medications from different categories or when taking ≥4 antihypertensives regardless of BP levels. |
DOI | 10.1093/ajh/hpac086 |
Alternate Journal | Am J Hypertens |
PubMed ID | 35882382 |